'Atmanirbhar Bharat' boost, will benefit 200 Indian firms, create 8,000 jobs
IAI has designed and developed 70-80 per cent of the MRSAM, including the Elta MF-STAR radar, which forms the heart of the system
The Union government has an ambition to create a $5 billion worth of defence equipment by 2025, a senior DRDO official said here on Friday
DRDO Chairman Dr G. Satheesh Reddy on Monday briefed Vice President M. Venkaiah Naidu about the various products and equipment developed indigenously by DRDO labs for management Covid pandemic
As per the sources, the missile flew for around 150 km with an indigenous cruise engine.
The drug comes in powder form in sachet and is taken orally by dissolving it in water.
On the sidelines of his speech, Dr Reddy mentioned the various initiatives and achievements of the country in the defence sector
The lightweight, fire-and-forget MPATGM, which is integrated with a thermal sight, was launched from a man-portable launcher by a two-man crew at a target that was mimicking a moving tank.
The missile will be offered for export; possibility of sales to east Asian and African countries
The DRDO successfully flight-tested the new-generation Akash surface-to-air missile system from an integrated test range off the Odisha coast on Wednesday.
The missile was launched from a man-portable launcher integrated with thermal site and the target was mimicking a tank
DMRL develops special steels and other super-alloys (such as those mixed with nickel) and then facilitates their commercial production by industrial units
The Defence Research and Development Organisation has indigenously developed a high-strength beta titanium alloy for manufacturing intricate components for aerospace applications
'Use of Artificial Intelligence by groups across border against India could happen. Working to defeat that too', said Amit Shah
The new rules, the ministry said, have been built on a premise of trust, self-certification and non-intrusive monitoring
Patented technology of US firm, which tied up with DRDO last month, to save 66,500 more people in July-August
The company has received a licence from DRDO to manufacture and market "2-Deoxy-D-Glucose" (2-DG) as approved medication for the treatment of COVID-19 patients
2DG has been given emergency approval by the Drugs Controller General of India (DCGI) for use on COVID-19 patients in the country, Laurus Labs said in a regulatory filing.
2-DG was developed by the Institute of Nuclear Medicine & Allied Sciences (INMAS), a laboratory of the Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy's
Agni-5 to be mainstay of anti-China arsenal, Agni-P deterrent against Pakistan